Document is current
Any future updates will be listed below
-
Authors
Messelink, Marianne A. https://orcid.org/0000-0002-6291-3134
Welsing, Paco M. J. https://orcid.org/0000-0003-2361-2803
Devercelli, Giovanna
Marsden, Jan Willem N.
Leavis, Helen L. https://orcid.org/0000-0001-8720-3684
- License Information
-
More Information
Article History
Received: 7 July 2023
Accepted: 27 August 2023
First Online: 16 September 2023
Change Date: 23 February 2024
Change Type: Update
Change Details: The original version of this paper was updated to present the missing supplementary materials.
Declarations
:
: This study was approved by the Medical Research Ethics Committee NedMec under protocol number NL74 944.041.20.
: All patients included for laboratory analysis provided written informed consent.
: All patients provided written informed consent for publication.
: MM has received research funding from Takeda Pharmaceuticals. GD is an employee of Takeda Pharmaceuticals, holds Amgen stocks, and is a member of the PCORI Advisory Panel for Rare Diseases. HL has received research funding, consulting fees, and speaker fees from Takeda Pharmaceuticals. All other authors declare no competing interests.
